Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01689779 · ClinicalTrials.gov registry record · Phase 3
High Dose Preoperative Cholecalciferol Supplementation and Perioperative Vitamin D Status
A Phase 3 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT01689779: Completed Phase 3 study, sponsored by Massachusetts General Hospital.
NCT01689779 is a Phase 3 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01689779, a Phase 3 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
A growing body of evidence suggests that robust postoperative immune function is associated with a lower risk of surgical site infections (SSIs). At the same time, vitamin D is increasingly recognized as a key regulator of the innate and adaptive immune systems. The investigators elected to conduct the current study in patients who will undergo colorectal surgery since these patients are historically at higher risk of developing SSIs and therefore would be ideal for future investigations.
Interventions
- DRUG Placebo
- DRUG 100,000 IU cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01689779
The ClinicalTrials.gov registry entry for NCT01689779 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01689779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01689779 about?
NCT01689779 is a clinical study titled "High Dose Preoperative Cholecalciferol Supplementation and Perioperative Vitamin D Status". A growing body of evidence suggests that robust postoperative immune function is associated with a lower risk of surgical site infections (SSIs). At the same time, vitamin D is increasingly recognized as a key regulator of the innate and adaptive immune systems. The investigators elected to conduct ...
What is the current status of trial NCT01689779?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2013-01. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01689779?
The interventions under investigation include: Placebo (DRUG), 100,000 IU cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT01689779?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.